Interferon receptor (IFNAR) isoforms |
multiple sclerosis |
[23] |
Enigma homolog splice variants (ENH 1-4) |
ENH1 promotes the expression of cardiac muscle hypertrophy markers, high levels of ENH4 prevent these changes |
[24] |
B-cell activating factor (BAFF) isoforms |
autoimmune diseases |
[25] |
T-cell factor 7-like 2 (TCF7L2) splice variants |
related to the development of type 2 diabetes |
[26] |
Forkhead family transcription factor (FOXP1) embryonic stem cell-specific isoform (FOXP1-ES) |
embryonic stem cell pluripotency and reprogramming regulation |
[27] |
Vascular endothelial growth factor (VEGF) splice variants |
anti-angiogenic properties in cancer therapy |
[98-99] |
Insulin-like growth factor-1 (IGF-I) splice variants (IGF-IEa, IGF-IEb and IGF-IEc) |
high resistance exercise |
[100] |
Interleukin IL37 and its splice variants |
anti-inflammatory cytokines |
[101] |
Fibronectin splice variants |
participate in lymphatic valve formation; prevent tissue fibrosis; mediate fibroblast to myofibroblast differentiation; pro-thrombotic role |
[102-103] |
Thrombopoietin splice variants |
pro-apoptotic causing death of newly generated neurons; risk of myocardial infarction |
[105-106] |
Neuregulin splice variants |
breast cancer; prostate cancer |
[22,107] |
Osteopontin splice variants (OPNa, OPNb and OPNc) |
OPNa is a major isoform in both healthy and non-small cell lung cancer (NSCLC) and it is elevated in NSCLC |
[108] |
p53 family (TP53, TP63 and TP73) splice variants |
high expression levels contribute to tumorigenesis; affect tumor response to therapy |
[109] |